69
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence

, , , , , , , , & show all
Pages 301-311 | Published online: 11 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Gabriel Kaplan, Julio Casoy & Jacqueline Zummo. (2013) Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia. Patient Preference and Adherence 7, pages 1171-1180.
Read now
Natalie C. Edwards, Erik Muser, Dilesh Doshi & John Fastenau. (2012) The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving. Journal of Medical Economics 15:4, pages 623-634.
Read now
Richard Newton, Harry Hustig, Raju Lakshmana, Joseph Lee, Balaji Motamarri, Peter Norrie, Robert Parker & Andreas Schreiner. (2012) Practical guidelines on the use of paliperidone palmitate in schizophrenia. Current Medical Research and Opinion 28:4, pages 559-567.
Read now
Miguel Bernardo, Luis San, José M Olivares, Tatiana Dilla, Pepa Polavieja, Inmaculada Gilaberte, María Álvarez & Antonio Ciudad. (2011) Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics. Patient Preference and Adherence 5, pages 601-610.
Read now
Katarina Kelin, Timothy JR Lambert, Alan JM Brnabic, Richard Newton, Wendy Ye, Raúl I Escamilla, Kuang-Peng Chen, Liana Don, William Montgomery, Jamie Karagianis & Haya Ascher-Svanum. (2011) Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence 5, pages 213-222.
Read now

Articles from other publishers (2)

Arnold P. M. van der Lee, Ibrahim Önsesveren, André I. Wierdsma, Roos van Westrhenen, Aartjan T. F. Beekman, Lieuwe de Haan & Niels C. L. Mulder. (2021) The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study. CNS Drugs.
Crossref
A. J. M. Brnabic, K. Kelin, H. Ascher-Svanum, W. Montgomery, Z. Kadziola & J. Karagianis. (2011) Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study. International Journal of Clinical Practice 65:9, pages 945-953.
Crossref